** Pfizer's PFE.N shares rise 1.7% to $23.44 premarket

** PFE posts Q1 adj EPS of $0.92, beating analysts' estimates of $0.67, per data compiled by LSEG

** While Q1 revenue misses estimates, but still sticks by FY revenue forecast of $61-$64 billion

** Also maintains FY adj EPS outlook of $2.80-$3.00

** As of last close, PFE has fallen about 13% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))